{"hq_id":"hq-c-org-001973","name":"Codeine","context":"human_adult","timestamp":"2026-09-10T08:49:30.539Z","risk_level":"moderate_to_high","risk_profile":{"magnitude":{"mean":0.475,"weightedMean":0.475,"std_dev":0,"confidence_interval_95":[0.475,0.475],"source_positions":[{"source":"HQ_DIRECT","year":2026,"value":0.475,"weight":0.35}]},"confidence":{"mean":0.5,"weightedMean":0.5,"std_dev":0,"confidence_interval_95":[0.5,0.5],"source_positions":[{"source":"HQ_DIRECT","year":2026,"value":0.5,"weight":0.35}]},"recency":{"mean":1,"weightedMean":1,"std_dev":0,"confidence_interval_95":[1,1],"source_positions":[{"source":"HQ_DIRECT","year":2026,"value":1,"weight":0.35}]},"methodology":{"mean":0.7,"weightedMean":0.7,"std_dev":0,"confidence_interval_95":[0.7,0.7],"source_positions":[{"source":"HQ_DIRECT","year":2026,"value":0.7,"weight":0.35}]},"specificity":{"mean":0.92,"weightedMean":0.92,"std_dev":0,"confidence_interval_95":[0.92,0.92],"source_positions":[{"source":"HQ_DIRECT","year":2026,"value":0.92,"weight":0.35}]},"consensus":{"exists":false,"strength":0,"disagreement_magnitude":0,"warning":"single_source_warning"}},"interpretation":{"summary":"Single source (HQ_DIRECT, 2026) indicates low to moderate risk.","confidence_note":"Evidence quality varies; interpretation requires caution.","context_note":null,"warning":"single_source_warning"},"sources":[{},{"id":"dea_codeine_schedules","type":"regulatory","title":"DEA Codeine scheduling (Schedule II / III / V depending on formulation)","year":2023},{"id":"who_essential_medicines_codeine_2023","type":"regulatory","title":"WHO Essential Medicines List — Codeine analgesic and antitussive","year":2023},{"id":"fda_codeine_label_pediatric_warning_2017","type":"regulatory","title":"FDA codeine label — pediatric contraindication for tonsillectomy/adenoidectomy","year":2017},{"id":"aspca_apcc_opioids","type":"industry","title":"ASPCA APCC opioid pet-toxicity reporting","year":2023}],"sources_scope":"record","warnings":["unmapped_classification:DEA:schedule ii controlled substance (pure) / schedule","unmapped_classification:WHO:essential medicine — step 2 analgesic ladder","single_source_warning"],"meta":{"synthesis_version":"1.1.0","config_version":"1.1.0","n_sources":1,"db_version":9,"warnings":["unmapped_classification:DEA:schedule ii controlled substance (pure) / schedule","unmapped_classification:WHO:essential medicine — step 2 analgesic ladder"]},"schema":"synthesis","_notice":"ALETHEIA output is reference data, not professional advice. Not a substitute for primary agency sources or qualified professionals. See https://aletheia.holisticquality.io/disclaimer.","_disclaimer_url":"https://aletheia.holisticquality.io/disclaimer","available_contexts":["human_adult","human_child","dog","cat","human_teen","human_elderly","human_infant","human_pregnant","exposure_dermal","exposure_inhalation","exposure_ingestion","exposure_ocular","occupational_exposure"]}